HSIC
Get informed when a big investor buys or sells
+ FollowOvervalued by 28% based on the discounted cash flow analysis.
| Market cap | $10.04 Billion |
|---|---|
| Enterprise Value | $13.89 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $3.29 |
| Beta | 0.81 |
| Outstanding Shares | 113,451,329 |
| P/E Ratio | 25.47 |
|---|---|
| PEG | 273.81 |
| Price to Sales | 0.76 |
| Price to Book Ratio | 2.2 |
| Enterprise Value to Revenue | 1.02 |
| Enterprise Value to EBIT | 18.75 |
| Enterprise Value to Net Income | 34 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 1.27 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0083▼ 13.67% |
|---|---|
| Total Calls | 60,300▼ 87.83% |
| Total Puts | 500▼ 99.30% |
Holdings and activity of institutional investors.
| Ownership % | 18.26%▼ 84.23% |
|---|---|
| Total Invested | $1.75B▼ 80.28% |
| Investors Holding | 272▼ 294.00% |
No data
Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 mi...